Literature DB >> 10227927

Artificial nutrition in cancer patients: which route, what composition?

F Bozzetti1, C Gavazzi, L Mariani, F Crippa.   

Abstract

The state of art of artificial nutrition in depleted cancer patients is reviewed in brief. Because cancer cachexia cannot be equated to simple nutrient deficiency but is due instead to complex metabolic abnormalities, the nutritional effects of total parenteral (TPN) and enteral (EN) nutrition are more limited than in starving subjects. TPN and EN usually prevent further deterioration of the nutritional status, although they are not able to fully reverse a state of depletion. There is evidence that quantitative and qualitative modulation of certain nutrients may obtain better results because of a favorable impact on host metabolism. Research in this field is fully warranted. Moreover, the effects of some substrates on tumor metabolism and tumor growth require further investigation to define a nutritional regimen able to maintain the host metabolism with minimum stimulation of tumor growth.

Entities:  

Mesh:

Year:  1999        PMID: 10227927     DOI: 10.1007/pl00012350

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

1.  Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial.

Authors:  Tanvi S Sharma; Lori J Bechard; Henry A Feldman; Robert Venick; Kathleen Gura; Catherine M Gordon; Andrew Sonis; Eva C Guinan; Christopher Duggan
Journal:  Am J Clin Nutr       Date:  2011-12-28       Impact factor: 7.045

Review 2.  Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.

Authors:  Hongjie Zhang; Jose M Garcia
Journal:  Expert Opin Pharmacother       Date:  2015-05-06       Impact factor: 3.889

3.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

4.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.